Leading Dermatology Research Solutions
We are dedicated to delivering precise evaluations and compassionate care through specialized expertise, ensuring impactful outcomes in clinical trials and therapeutic development.
The Dermatology CRO
hVIVO, together with CRS Berlin, provides industry-leading dermatology research solutions backed by deep early-phase expertise and a proven track record across atopic dermatitis, psoriasis, and contact hypersensitivity research. CRS Berlin operates as hVIVO's preferred partner for specialised dermatology clinical trials, combining Berlin-based dermatology infrastructure with hVIVO's global CRO capabilities.
- Specialist expertise in early-phase dermatology studies, including atopic dermatitis and psoriasis
- Comprehensive clinical assessment capabilities, including SCORAD, PASI, EASI, and skin and adipose tissue biopsies
- Irritation and sensitisation testing from topical applications, plus skin prick tests for immediate allergic responses
- Rigorous safety monitoring and compliance maintained throughout all trial phases
- Rapid patient and volunteer recruitment supported by an advanced enrolment database
Scientific & Technical Capabilities
Clinical Disease Assessments
-
SCORAD (Scoring Atopic Dermatitis)
-
PASI (Psoriasis Area & Severity Index)
-
EASI Score (Eczema Area & Severity Index)
-
IGA (Investigator Global Assessment)
-
DLQI (Dermatology Life Quality Index)
Skin & Tissue Procedures
-
Skin biopsies (punch and shave)
-
Adipose tissue biopsies
-
Tape-stripping for transepidermal water loss (TEWL) measurement
-
Skin barrier function assessment
Irritation & Sensitisation Testing
-
Topical application irritation testing
-
Repeat Insult Patch Test (RIPT)
-
Sensitisation profiling
-
Cumulative irritation studies
Allergy & Hypersensitivity
-
Skin prick tests for immediate allergic reactions (Type I hypersensitivity)
-
Patch testing for contact allergic dermatitis (Type IV reactions)
-
Intradermal testing protocols
Indications Studied
- Atopic dermatitis
- Psoriasis (plaque, guttate)
- Contact dermatitis
- Urticaria
- Lichen planus
- Alopecia
- Hyperpigmentation
Special Population and Patient Experience
Special Populations
-
Atopic / allergic phenotypes
-
Paediatric-adjacent adult cohorts
-
Mild, moderate, and severe disease stratifications
-
Steroid-naive and previously treated patients
Patient Populations
- Atopic dermatitis patients
- Psoriasis patients
- Contact dermatitis sufferers
- Healthy volunteers for tolerability studies
- Hypersensitivity populations
Delivery Through Our Partner Network
Specialist Expertise
As a preferred partner of the hVIVO Group, CRS Berlin provides industry-leading dermatology research solutions designed to deliver high-quality, reliable data and accelerate product development.
CRS Berlin offers extensive experience in early-phase dermatology studies, with a focus on atopic dermatitis and psoriasis. With a proven track record in supporting sponsors through every stage of dermatological product development — from concept to clinical validation – they drive impactful trial outcomes and innovative new therapies.
Integrated Research Networks
Through their own dedicated specialists and facilities, alongside collaborations with external dermatologists and large outpatient networks, CRS Berlin ensures unmatched recruitment capabilities. CRS’ advanced volunteer and patient database enables rapid enrolment for a diverse range of dermatology trials, supporting fast, efficient study start-up and delivery.
Advanced Assessment Capabilities
Employing clinical assessment tools such as SCORAD, PASI, and EASI, alongside expertise in skin and adipose tissue biopsies, CRS Berlin’s capabilities include irritation and sensitization testing for topical applications, skin prick tests for immediate allergic responses, and comprehensive safety monitoring throughout all trial phases.
End-to-End Drug Development Support
The hVIVO group provides end-to-end drug development support and has standalone and full-service offerings spanning regulatory strategy and submission support, CMC and PK/PD consultancy, project management, data management, and biostatistics services. With an established database of over 400,000 participants — including participants with cardiovascular, metabolic, and women's health-specific diseases — hVIVO can ensure your studies run seamlessly from start to finish, with dedicated recruitment, screening, and retention strategies tailored to female cohorts.
hVIVO, through CRS Berlin, provides a full range of early-phase dermatology services including clinical scoring, skin biopsies, irritation and sensitisation testing, and patch and prick testing for allergic reactions.
Yes. CRS Berlin has extensive experience in early-phase studies focused on atopic dermatitis and psoriasis, including proof-of-concept and Phase II trials.
Available tools include SCORAD, PASI, EASI, IGA, DLQI, TEWL measurement, and skin barrier function assessments.
Key focus areas include atopic dermatitis, psoriasis, contact dermatitis, urticaria, and hyperpigmentation.
Yes. hVIVO supports early-phase dermatology studies from Phase I tolerability through to Phase II proof-of-concept.
Plan your next Dermatology Trial with hVIVO
Find out how hVIVO can help you accelerate your dermatology research programme.